| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $230.5M | -2.2% |
| Cost of Revenue | $64.4M | +2.7% |
| R&D Expense | $54.9M | +9.0% |
| SG&A Expense | $80.2M | -10.9% |
| Operating Income | $31.0M | -5.1% |
| Pre-tax Income | $24.1M | +6.3% |
| Income Tax | -$6.2M | -670.5% |
| Net Income | $30.3M | +40.2% |
| EPS (Basic) | $0.62 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $69.2M | -18.2% |
| Short-term Investments | $31.7M | +179.6% |
| Accounts Receivable | $32.0M | -33.1% |
| Inventory | $8.7M | +23.2% |
| Current Assets | $147.7M | -5.5% |
| Total Assets | $213.3M | -7.5% |
| Current Liabilities | $96.1M | -3.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $38.9M | +44.1% |
| Capital Expenditures | $56K | -60.0% |
| Investing Cash Flow | -$20.4M | -6.9% |
| Financing Cash Flow | -$33.8M | — |
| Free Cash Flow | $38.9M | +44.6% |
| +34.8% |
| EPS (Diluted) | $0.62 | +37.8% |
| Long-term Debt |
| $68.0M |
| -33.3% |
| Total Liabilities | $121.2M | -31.6% |
| Stockholders' Equity | $92.1M | +72.4% |